This live in-person workshop will focus on the challenges associated with formulation and clinical trial manufacture of biologics to the nasal cavity, as well as the barriers to cell penetration and absorption. The workshop will be presented by three of Aptar Pharma’s renowned experts on nasal drug delivery as well as an expert from Enteris Biopharma, a key partner in nasal drug delivery. Our impressive panel of experts includes Dr Jag Shur, VP Science & Technology, Nanopharm, an Aptar Pharma company, Dr Irene Rossi, Head of New Modalities Pharmaceutical Development, Nanopharm, Dr Julie Suman, Vice President Scientific Affairs, Aptar Pharma and Dr Paul Shields, CEO, Enteris Biopharma Inc.
The event will cover the pros and cons of liquid versus powder formulations, and formulations and strategies for maintaining stability and prolonging retention in the nasal cavity, in addition to highlighting ways for maintaining stability and prolonging retention in the nasal cavity. The workshop will also cover device selection for preclinical and clinical studies using predictive tools such as nasal casts.
The workshop will also provide the audience with manufacturing strategies for clinical trials with nasally administered biologics. The participants who would benefit from this workshop include research and development, formulation development, clinical development, CMC managers, program management, development engineers and clinical trial manufacturing personnel. Attendees will leave with a comprehensive understanding of nasal drug delivery and the future of biologics, and will gain valuable insights into the barriers to cell penetration and absorption, as well as the identification of an ideal target product profile.
“We are thrilled to partner with IPI to bring this educational workshop on nasal drug delivery to the pharmaceutical industry,” said Dr Julie Suman, Vice President Scientific Affairs, Aptar Pharma. “Our experts will provide valuable insights into the challenges and strategies associated with delivering biologics to the nasal cavity. These workshops will be an excellent opportunity for pharmaceutical professionals to gain knowledge and network with their peers.”
The educational workshops are open to all pharmaceutical professionals interested in nasal drug delivery.
Register now to secure your spot at this informative event on February 6, 2024.
Review the program of Delivery of Biologics to the Nasal Cavity
About Aptar Pharma
Aptar Pharma is an expert in nasal drug delivery, offering advanced intranasal devices and drug delivery services from device design and manufacture, formulation development and clinical product manufacturing to post launch support. Our global network of GMP manufacturing sites help us accelerate and derisk drug product development, and our investments in R&D and innovation allow us to offer proven nasal drug delivery solutions to help improve patient outcomes across the globe. For more information, please visit https://aptar.com/pharma/.
About IPI Academy
International Professional & Industry Academy (IPI) is an international leading professional training organisation based in London. Our training solutions provide a return on your investment with measurable results, and are delivered by experienced professionals and managed with exceptional care and attention. With our network of over 1,000 carefully selected and internationally renowned presenters, trainers, consultants, global industry leaders, authors and training partners, the IPI Academy delivers an all-encompassing international skills training and development service. Our events are designed to be highly practical and interactive, maximising the breadth of our speakers’ experience and knowledge. A particular focus on using hands-on teaching methods including highly specific case studies and examples allow delegates to ‘dry run’ skills and techniques with an industry professional before applying them in your own professional setting.
